Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder

PURPOSE/BACKGROUND: Major depressive disorder (MDD) and obesity commonly co-occur. We sought to assess the impact of Body Mass Index (BMI) on the acute antidepressant effects of ketamine in patients with treatment resistant depression (TRD). METHODS/PROCEDURES: Post-hoc analyses were conducted from...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Psychopharmacol
Autori principali: Freeman, Marlene P., Hock, Rebecca S., Papakostas, George I., Judge, Heidi, Cusin, Cristina, Mathew, Sanjay J., Sanacora, Gerard, Iosifescu, Dan V., DeBattista, Charles, Trivedi, Madhukar H., Fava, Maurizio
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185034/
https://ncbi.nlm.nih.gov/pubmed/32332464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001209
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi